Clinical Trials
95 trialsGRECCAR12
University Hospital, Bordeaux
ETAP
Institut Paoli-Calmettes
00-046
Memorial Sloan Kettering Cancer Center
GRECCAR8
Hospices Civils de Lyon
MTM-COLON-II
Centre Hospitalier Universitaire, Amiens
RIFIONA
Centre Hospitalier Universitaire, Amiens
FIDURA
Sahlgrenska University Hospital
Néofirinox
UNICANCER
COLORII
Nova Scotia Health Authority
Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer
Memorial Sloan Kettering Cancer Center
NACRE
UNICANCER
CAIRO4
Dutch Colorectal Cancer Group
Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
Canadian Cancer Trials Group
Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer
Canadian Cancer Trials Group
GRECCAR1
Institut du Cancer de Montpellier - Val d'Aurelle
Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
Eastern Cooperative Oncology Group
GASVERT
Institut de Cancérologie de Lorraine
Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer
Amgen
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
Alliance for Clinical Trials in Oncology
ASPECCT: A Study of Panitumumab Efficacy and Safety Compared to Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer
Amgen
GRECCAR6
Assistance Publique - Hôpitaux de Paris
Irinotecan With or Without Panitumumab or Cyclosporine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Fluorouracil
University of Leeds
SURVEILLANCE
Federation Francophone de Cancerologie Digestive
Preoperative Chemoradiotherapy and Transanal Endoscopic Microsurgery Versus Total Mesorectal Excision in T2-T3s N0, M0 Rectal Cancer
Corporacion Parc Tauli
Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Medical Research Council
BIOPEX
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Radiation Therapy and Capecitabine With or Without Oxaliplatin in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Rectal Cancer
UNICANCER
RectumSIB
Universitair Ziekenhuis Brussel
Rektum-III
Universitätsmedizin Mannheim
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Alliance for Clinical Trials in Oncology
Laparoscopic-Assisted Resection or Open Resection in Treating Patients With Rectal Cancer
Alliance for Clinical Trials in Oncology
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Alliance for Clinical Trials in Oncology
Immediate Compared With Delayed Chemotherapy in Advanced Colorectal Cancer Without Signs or Symptoms of Disease
Canadian Cancer Trials Group
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
Novartis
ACP
SWOG Cancer Research Network
Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer
Swiss Cancer Institute
Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer
National Cancer Institute (NCI)
PACCE: Panitumumab Advanced Colorectal Cancer Evaluation Study
Amgen
Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer
Cancer Research UK, Glasgow
NERATEM
European Association for Endoscopic Surgery
GRECCAR 2
University Hospital, Bordeaux
PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study
Amgen
CPTD
Johns Hopkins Bloomberg School of Public Health
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
Novartis
MTM-COLON-I
Centre Hospitalier Universitaire, Amiens
PETACC-6
European Organisation for Research and Treatment of Cancer - EORTC
Influence of Somatuline Autogel 120mg on Post-operative Drainage After Total Mesorectum Excision for Rectumcarcinoma
University Hospital, Ghent
Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II, III Lower Rectal Cancer (JCOG0212)
Japan Clinical Oncology Group
Radiation Therapy, Surgery, and Chemotherapy in Treating Patients With Rectal Cancer That Can Be Surgically Removed
European Organisation for Research and Treatment of Cancer - EORTC